274 related articles for article (PubMed ID: 28240973)
21. Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma.
Borchmann S; Cirillo M; Goergen H; Meder L; Sasse S; Kreissl S; Bröckelmann PJ; von Tresckow B; Fuchs M; Ullrich RT; Engert A
J Clin Oncol; 2019 Dec; 37(36):3528-3537. PubMed ID: 31622132
[TBL] [Abstract][Full Text] [Related]
22. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
[TBL] [Abstract][Full Text] [Related]
23. Pregnancy and the Risk of Relapse in Patients Diagnosed With Hodgkin Lymphoma.
Weibull CE; Eloranta S; Smedby KE; Björkholm M; Kristinsson SY; Johansson AL; Dickman PW; Glimelius I
J Clin Oncol; 2016 Feb; 34(4):337-44. PubMed ID: 26668344
[TBL] [Abstract][Full Text] [Related]
24. Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Eichenauer DA; Müller H; Elger L; Goergen H; Fuchs M; Kreissl S; Böll B; Diehl V; von Tresckow B; Borchmann P; Engert A
Br J Haematol; 2021 May; 193(3):515-519. PubMed ID: 33486762
[TBL] [Abstract][Full Text] [Related]
25. ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials.
Böll B; Görgen H; Fuchs M; Pluetschow A; Eich HT; Bargetzi MJ; Weidmann E; Junghanß C; Greil R; Scherpe A; Schmalz O; Eichenauer DA; von Tresckow B; Rothe A; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2013 Apr; 31(12):1522-9. PubMed ID: 23509310
[TBL] [Abstract][Full Text] [Related]
26. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
28. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
29. Thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials.
Borchmann S; Müller H; Hude I; Fuchs M; Borchmann P; Engert A
Ann Oncol; 2019 Aug; 30(8):1329-1334. PubMed ID: 31132094
[TBL] [Abstract][Full Text] [Related]
30. [Clinical characteristics and prognostic factors of 62 cases with Hodgkin lymphoma].
Wan WL; Tian L; Wang J; Zhang W; Jing HM; Wang JJ; Liu Y; Hou SL; Ke XY
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):618-21. PubMed ID: 23906458
[TBL] [Abstract][Full Text] [Related]
31. Hodgkin lymphoma in Tyrol-a population-based study.
Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin lymphoma at Groote Schuur Hospital, South Africa: the effect of HIV and bone marrow infiltration.
Swart L; Novitzky N; Mohamed Z; Opie J
Ann Hematol; 2019 Feb; 98(2):381-389. PubMed ID: 30397846
[TBL] [Abstract][Full Text] [Related]
33. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Majhail NS; Weisdorf DJ; Defor TE; Miller JS; McGlave PB; Slungaard A; Arora M; Ramsay NK; Orchard PJ; MacMillan ML; Burns LJ
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1065-72. PubMed ID: 17084370
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: a retrospective study.
Yang M; Ping L; Liu W; Xie Y; Aliya ; Liu Y; Nuersulitan R; Zhu J; Wu M; Song Y
Hematology; 2019 Dec; 24(1):413-419. PubMed ID: 30922173
[TBL] [Abstract][Full Text] [Related]
35. High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence.
Tarella C; Cuttica A; Vitolo U; Liberati M; Di Nicola M; Cortelazzo S; Rosato R; Rosanelli C; Di Renzo N; Musso M; Pavone E; Santini G; Pescarollo A; De Crescenzo A; Federico M; Gallamini A; Pregno P; Romano R; Coser P; Gallo E; Boccadoro M; Barbui T; Pileri A; Gianni AM; Levis A
Cancer; 2003 Jun; 97(11):2748-59. PubMed ID: 12767087
[TBL] [Abstract][Full Text] [Related]
36. Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.
Torok JA; Wu Y; Prosnitz LR; Kim GJ; Beaven AW; Diehl LF; Kelsey CR
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):54-9. PubMed ID: 25863754
[TBL] [Abstract][Full Text] [Related]
37. Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century.
Pulte D; Jansen L; Gondos A; Emrich K; Holleczek B; Katalinic A; Brenner H;
Br J Haematol; 2014 Mar; 164(6):851-7. PubMed ID: 24433418
[TBL] [Abstract][Full Text] [Related]
38. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.
Hodgson DC; Gilbert ES; Dores GM; Schonfeld SJ; Lynch CF; Storm H; Hall P; Langmark F; Pukkala E; Andersson M; Kaijser M; Joensuu H; Fosså SD; Travis LB
J Clin Oncol; 2007 Apr; 25(12):1489-97. PubMed ID: 17372278
[TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis of 135 newly diagnosed patients with Hodgkin lymphoma].
Zhou J; Wu X; Dai Y; Liu T; Xu C
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):304-8. PubMed ID: 24759017
[TBL] [Abstract][Full Text] [Related]
40. Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration.
Behringer K; Goergen H; Müller H; Thielen I; Brillant C; Kreissl S; Halbsguth TV; Meissner J; Greil R; Moosmann P; Shonukan O; Rueffer JU; Flechtner HH; Fuchs M; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2016 Dec; 34(36):4329-4337. PubMed ID: 27998235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]